These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The association of comorbid depression with mortality and amputation risk in patients with chronic limb-threatening ischemia. Zielke T; Korepta L; Wesolowski M; D'Andrea M; Aulivola B J Vasc Surg; 2024 Jan; 79(1):96-101.e1. PubMed ID: 37704093 [TBL] [Abstract][Full Text] [Related]
23. Association Between Diagnosis-to-Limb Revascularization Time and Clinical Outcomes in Outpatients With Chronic Limb-Threatening Ischemia: Insights From the CLIPPER Cohort. Fanaroff AC; Dayoub EJ; Yang L; Schultz K; Ramadan OI; Wang GJ; Damrauer SM; Genovese EA; Secemsky EA; Parikh SA; Nathan AS; Kohi MP; Weinberg MD; Jaff MR; Groeneveld PW; Giri JS J Am Heart Assoc; 2024 May; 13(9):e033898. PubMed ID: 38639376 [TBL] [Abstract][Full Text] [Related]
24. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations. Darling JD; McCallum JC; Soden PA; Guzman RJ; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML J Vasc Surg; 2017 Mar; 65(3):695-704. PubMed ID: 28073665 [TBL] [Abstract][Full Text] [Related]
25. Multiple Reinterventions for Claudication are Associated with Progression to Chronic Limb-Threatening Ischemia. Kim TI; Kiwan G; Mohamedali A; Zhang Y; Dardik A; Guzman RJ; Ochoa Chaar CI Ann Vasc Surg; 2021 Apr; 72():166-174. PubMed ID: 33227462 [TBL] [Abstract][Full Text] [Related]
26. Long-Term Outcomes of Exercise Therapy Versus Revascularization in Patients With Intermittent Claudication. Shirasu T; Takagi H; Yasuhara J; Kuno T; Kent KC; Farivar BS; Tracci MC; Clouse WD Ann Surg; 2023 Aug; 278(2):172-178. PubMed ID: 36728522 [TBL] [Abstract][Full Text] [Related]
27. The Double Burden: Deciphering Chronic Limb-Threatening Ischemia in End-Stage Renal Disease. Nakhaei P; Hamouda M; Malas MB Ann Vasc Surg; 2024 Oct; 107():105-121. PubMed ID: 38599491 [TBL] [Abstract][Full Text] [Related]
28. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions. Alameddine D; Damara FA; Pinto Rodriguez P; Huttler J; Slade MD; Arhuidese I; Aboian E; Ochoa Chaar CI Ann Vasc Surg; 2024 Jun; 103():47-57. PubMed ID: 38387798 [TBL] [Abstract][Full Text] [Related]
29. Aorto-iliac and infrainguinal artery occlusive disease: different revascularization options according to the critical limb threatening ischemia category. Pini R; Faggioli G; Angherà C; Cappiello A; Abualhin M; Pomatto S; Gallitto E; Gargiulo M Int Angiol; 2023 Jun; 42(3):209-215. PubMed ID: 37067388 [TBL] [Abstract][Full Text] [Related]
30. Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease. Bodewes TCF; Darling JD; Deery SE; O'Donnell TFX; Pothof AB; Shean KE; Moll FL; Schermerhorn ML J Vasc Surg; 2018 Jan; 67(1):206-216.e2. PubMed ID: 28844467 [TBL] [Abstract][Full Text] [Related]
31. Severe inframalleolar disease is an independent predictor of adverse limb outcomes after endovascular revascularization in chronic limb-threatening ischemia. Naiem AA; Bergeron A; MacKenzie KS; Obrand DI; Steinmetz OK; Bayne JP; Gill HL; Girsowicz E J Vasc Surg; 2023 Mar; 77(3):858-863. PubMed ID: 36332807 [TBL] [Abstract][Full Text] [Related]
34. Lower Extremity Revascularization for Chronic Limb-Threatening Ischemia among Patients at the Extremes of Age. Kim TI; Aboian E; Fischer U; Zhang Y; Guzman RJ; Ochoa Chaar CI Ann Vasc Surg; 2021 Apr; 72():517-528. PubMed ID: 32927042 [TBL] [Abstract][Full Text] [Related]
35. Major Adverse Limb Events Among Patients with Premature Peripheral Artery Disease Compared with Those at the Common Age Undergoing Revascularization in the Vascular Quality Initiative. Kim TI; Loh S; DeWan A; Murray M; Mojibian H; Mani A; Mena-Hurtado C; Ochoa Chaar CI Ann Vasc Surg; 2022 Nov; 87():188-197. PubMed ID: 35926786 [TBL] [Abstract][Full Text] [Related]
36. Cancer should not contravene the revascularization of chronic limb-threatening ischaemia. Jessen ML; Eiberg J; Sillesen H; Lawaetz M Vascular; 2024 Apr; 32(2):330-336. PubMed ID: 36274575 [TBL] [Abstract][Full Text] [Related]
37. Physical and psychological functioning of patients with chronic limb ischemia during a 1-year period after endovascular revascularization. Banaś W; Czerniak B; Budzyński J J Vasc Surg; 2022 May; 75(5):1679-1686. PubMed ID: 34695554 [TBL] [Abstract][Full Text] [Related]
38. Differences in major limb outcomes by indication for lower extremity endovascular revascularization in patients receiving hemodialysis. Iwai T; Yamaguchi T; Ueshima D; Tobita K; Mizuno A; Fujimoto Y; Miyazaki R; Shimura T; Goto R; Murata N; Anzai H; Higashitani M Heart Vessels; 2023 Apr; 38(4):488-496. PubMed ID: 36322238 [TBL] [Abstract][Full Text] [Related]
39. Contemporary outcomes of limb-salvage procedures using Vascular Quality Initiative-Medicare-linked data: Racial and ethnic disparities persist. Mathlouthi A; Zarrintan S; Khan MA; Malas M; Barleben A J Vasc Surg; 2022 Jun; 75(6):2013-2018. PubMed ID: 35149160 [TBL] [Abstract][Full Text] [Related]
40. Racial and ethnic disparities in 3-year outcomes following infrainguinal bypass for chronic limb-threatening ischemia. Anjorin AC; Marcaccio CL; Patel PB; Wang SX; Rowe V; Aulivola B; Wyers MC; Schermerhorn ML J Vasc Surg; 2022 Nov; 76(5):1335-1346.e7. PubMed ID: 35768062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]